Loading...
NPI 1902141914 · Port Jefferson Station, NY · Hematology & Oncology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Amishi Desai is a hematology & oncology physician provider located in Port Jefferson Station, New York. This profile covers 107 Medicare and 46 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Amishi Desai |
| Address | 1500 Route 112 Bldg 4 |
| City | Port Jefferson Station |
| State | NY |
| ZIP | 11776 |
| Taxonomy | Hematology & Oncology Physician |
| NPI Enumerated | December 2, 2012 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.2M |
| Medicaid | $431.4K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
107 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 15,200 | $40 | $653.6K |
| J0897 | Injection, denosumab, 1 mg | 11,220 | $20 | $213.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,760 | $110 | $200.6K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 131,250 | $1 | $131.3K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 880 | $110 | $97.2K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 4,110 | $20 | $94.5K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,360 | $30 | $77.9K |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 2,780 | $20 | $61.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 450 | $130 | $57.7K |
| 99490 | The clinical staff provides services directed by the provider to support and coordinate a patient’s care across multiple disciplines. The patient has two or more chronic conditions that place the… | 1,030 | $60 | $57.4K |
Showing 1–10 of 107
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 107 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
107 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9271 | 15 | 60 | 9,900 | $40 | $505.5K |
| J1568 | 19 | 30 | 2,880 | $30 | $113.4K |
| Q5107 | 2 | 10 | 4,580 | $20 | $103K |
| J0897 | 39 | 490 | 2,820 | $20 | $84.4K |
| 88185 | 27 | 100 | 1,210 | $20 | $74.9K |
| J1439 | 3 | 90 | 39,750 | $1 | $42K |
| J0881 | 54 | 80 | 13,100 | $1 | $41K |
| 80307 | 69 | 120 | 70 | $60 | $23.1K |
| 99490 | 113 | 1,210 | 150 | $50 | $21K |
| J1454 | 7 | 40 | 50 | $340 | $20.5K |
Showing 1–10 of 107
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
46 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,430 | $60 | $150.7K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 120 | $580 | $67.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 650 | $40 | $23.5K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 40 | $530 | $22.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 3,290 | $1 | $13.2K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 580 | $20 | $12.2K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,990 | $10 | $12K |
| 82728 | The lab analyst measures the level of ferritin, an important protein composed of about 20 percent iron. Ferritin also acts as an iron reserve in the body, and is present in serum in only minute… | 1,410 | $10 | $11.3K |
| J1756 | Injection, iron sucrose, 1 mg | 440 | $30 | $10.9K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 270 | $40 | $10.4K |
Showing 1–10 of 46
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
46 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 201 | 210 | 2,850 | $180 | $1.1M |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 134 | 200 | 630 | $150 | $338K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 20 | 40 | 160 | $590 | $323.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 11,859 | 19,110 | 360 | $70 | $321K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 215 | 430 | 680 | $120 | $299.9K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 263 | 590 | 1,160 | $20 | $277.2K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 29 | 40 | 480 | $200 | $223.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,048 | 16,550 | 220 | $90 | $186.8K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 226 | 380 | 1,130 | $20 | $179K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 115 | 170 | 210 | $20 | $162.3K |
Showing 1–10 of 46
Other providers in the same ZIP code as Amishi Desai, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Long Island Digestive Endoscopy Center, LLC | NY | Ambulatory Surgical Clinic/Center | $1.6M | $1.4M |
| Regina Jablonski | NY | Hematology & Oncology Physician | $2.8M | $39.3K |
| George Cyriac | NY | Hematology & Oncology Physician | $2.7M | $14.5K |
| Adriana Guigova | NY | Hematology & Oncology Physician | $2.3M | $46.9K |
| Alfredo Torres Gonzalez | NY | Hematology & Oncology Physician | $1.9M | $16K |
| Joshua Harris | NY | Hematology & Oncology Physician | $1.6M | $62.3K |
| Port Jefferson Asc, LLC | NY | Ambulatory Surgical Clinic/Center | $1.5M | $0 |
| Jerry George | NY | Hematology & Oncology Physician | $1.4M | $59.5K |
| Eric Mitchnick | NY | Urology Physician | $1.2M | $0 |
| Varghese Cherian | NY | Diagnostic Radiology Physician | $976.5K | $155.3K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.